Skip to main content
Erschienen in:

25.02.2021 | Clinical Investigation

Regional differences in genes and variants causing retinitis pigmentosa in Japan

verfasst von: Yoshito Koyanagi, Masato Akiyama, Koji M Nishiguchi, Yukihide Momozawa, Yoichiro Kamatani, Sadaaki Takata, Chihiro Inai, Yusuke Iwasaki, Mikako Kumano, Yusuke Murakami, Shiori Komori, Dan Gao, Kentaro Kurata, Katsuhiro Hosono, Shinji Ueno, Yoshihiro Hotta, Akira Murakami, Hiroko Terasaki, Yuko Wada, Toru Nakazawa, Tatsuro Ishibashi, Yasuhiro Ikeda, Michiaki Kubo, Koh-Hei Sonoda

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the regional differences in the genes and variants causing retinitis pigmentosa (RP) in Japan

Study design

Retrospective multicenter study

Methods

In total, 1204 probands of each pedigree clinically diagnosed with nonsyndromic RP were enrolled from 5 Japanese facilities. The regions were divided into the Tohoku region, the Kanto and Chubu regions, and the Kyushu region according to the location of the hospitals where the participants were enrolled. We compared the proportions of the causative genes and the distributions of the pathogenic variants among these 3 regions.

Results

The proportions of genetically solved cases were 29.4% in the Tohoku region (n = 500), 29.6% in the Kanto and Chubu regions (n = 196), and 29.7% in the Kyushu region (n = 508), which did not differ statistically (P = .99). No significant regional differences in the proportions of each causative gene in genetically solved patients were observed after correction by multiple testing. Among the 29 pathogenic variants detected in all 3 regions, only p.(Pro347Leu) in RHO was an autosomal dominant variant; the remaining 28 variants were found in autosomal recessive genes. Conversely, 78.6% (275/350) of the pathogenic variants were detected only in a single region, and 6 pathogenic variants (p.[Asn3062fs] in EYS, p.[Ala315fs] in EYS, p.[Arg872fs] in RP1, p.[Ala126Val] in RDH12, p.[Arg41Trp] in CRX, and p.[Gly381fs] in PRPF31) were frequently found in ≥ 4 patients in the single region.

Conclusion

We observed region-specific pathogenic variants in the Japanese population. Further investigations of causative genes in multiple regions in Japan will contribute to the expansion of the catalog of genetic variants causing RP.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809.CrossRef Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809.CrossRef
2.
Zurück zum Zitat Campochiaro PA, Mir TA. The mechanism of cone cell death in retinitis pigmentosa. Prog Retin Eye Res. 2018;62:24–37.CrossRef Campochiaro PA, Mir TA. The mechanism of cone cell death in retinitis pigmentosa. Prog Retin Eye Res. 2018;62:24–37.CrossRef
3.
Zurück zum Zitat Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63:26–33.CrossRef Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63:26–33.CrossRef
4.
Zurück zum Zitat Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–86.CrossRef Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–86.CrossRef
5.
Zurück zum Zitat Dias MF, Joo K, Kemp JA, Fialho SL, da Silva CA, Woo SJ, et al. Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives. Prog Retin Eye Res. 2018;63:107–31.CrossRef Dias MF, Joo K, Kemp JA, Fialho SL, da Silva CA, Woo SJ, et al. Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives. Prog Retin Eye Res. 2018;63:107–31.CrossRef
6.
Zurück zum Zitat Nishiguchi KM, Fujita K, Miya F, Katayama S, Nakazawa T. Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice. Nat Commun. 2020;11:482.CrossRef Nishiguchi KM, Fujita K, Miya F, Katayama S, Nakazawa T. Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice. Nat Commun. 2020;11:482.CrossRef
7.
Zurück zum Zitat Carrigan M, Duignan E, Malone CP, Stephenson K, Saad T, McDermott C, et al. Panel-based population next-generation sequencing for inherited retinal degenerations. Sci Rep. 2016;6:33248.CrossRef Carrigan M, Duignan E, Malone CP, Stephenson K, Saad T, McDermott C, et al. Panel-based population next-generation sequencing for inherited retinal degenerations. Sci Rep. 2016;6:33248.CrossRef
8.
Zurück zum Zitat Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100:75–90.CrossRef Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100:75–90.CrossRef
9.
Zurück zum Zitat Stone EM, Andorf JL, Whitmore SS, DeLuca AP, Giacalone JC, Streb LM, et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology. 2017;124:1314–31.CrossRef Stone EM, Andorf JL, Whitmore SS, DeLuca AP, Giacalone JC, Streb LM, et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology. 2017;124:1314–31.CrossRef
10.
Zurück zum Zitat Ellingford JM, Barton S, Bhaskar S, O’Sullivan J, Williams SG, Lamb JA, et al. Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016;53:761–7.CrossRef Ellingford JM, Barton S, Bhaskar S, O’Sullivan J, Williams SG, Lamb JA, et al. Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016;53:761–7.CrossRef
11.
Zurück zum Zitat Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Investig Ophthalmol Vis Sci. 2014;55:7369–75.CrossRef Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Investig Ophthalmol Vis Sci. 2014;55:7369–75.CrossRef
12.
Zurück zum Zitat Gao F-J, Li J-K, Chen H, Hu F-Y, Zhang S-H, Qi Y-H, et al. Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa. Ophthalmology. 2019;126:1549–56.CrossRef Gao F-J, Li J-K, Chen H, Hu F-Y, Zhang S-H, Qi Y-H, et al. Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa. Ophthalmology. 2019;126:1549–56.CrossRef
13.
Zurück zum Zitat Maeda A, Yoshida A, Kawai K, Arai Y, Akiba R, Inaba A, et al. Development of a molecular diagnostic test for retinitis pigmentosa in the Japanese population. Jpn J Ophthalmol. 2018;62:451–7.CrossRef Maeda A, Yoshida A, Kawai K, Arai Y, Akiba R, Inaba A, et al. Development of a molecular diagnostic test for retinitis pigmentosa in the Japanese population. Jpn J Ophthalmol. 2018;62:451–7.CrossRef
14.
Zurück zum Zitat Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. 2020;127:1384–94.CrossRef Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. 2020;127:1384–94.CrossRef
15.
Zurück zum Zitat Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet. 2019;56:662–70.CrossRef Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet. 2019;56:662–70.CrossRef
16.
Zurück zum Zitat Hayakawa M, Matsumura M, Ohba N, Matsui M, Fujiki K, Kanai A, et al. A multicenter study of typical retinitis pigmentosa in Japan. Jpn J Ophthalmol. 1993;37:156–64.PubMed Hayakawa M, Matsumura M, Ohba N, Matsui M, Fujiki K, Kanai A, et al. A multicenter study of typical retinitis pigmentosa in Japan. Jpn J Ophthalmol. 1993;37:156–64.PubMed
17.
Zurück zum Zitat Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, et al. Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol. 1997;41:1–6. Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, et al. Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol. 1997;41:1–6.
18.
Zurück zum Zitat Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, et al. Multicenter genetic study of retinitis pigmentosa in Japan: II. Prevalence of autosomal recessive retinitis pigmentosa. Jpn J Ophthalmol. 1997;41:7–11.CrossRef Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, et al. Multicenter genetic study of retinitis pigmentosa in Japan: II. Prevalence of autosomal recessive retinitis pigmentosa. Jpn J Ophthalmol. 1997;41:7–11.CrossRef
19.
Zurück zum Zitat Ikesugi K, Ichio T, Tsukitome H, Kondo M. Annual incidences of visual impairment during 10-year period in Mie prefecture. Japan Jpn J Ophthalmol. 2017;61:293–8.CrossRef Ikesugi K, Ichio T, Tsukitome H, Kondo M. Annual incidences of visual impairment during 10-year period in Mie prefecture. Japan Jpn J Ophthalmol. 2017;61:293–8.CrossRef
20.
Zurück zum Zitat Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum Mol Genet. 2016;25:5027–34.PubMed Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum Mol Genet. 2016;25:5027–34.PubMed
21.
Zurück zum Zitat Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1–9. CrossRef Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1–9. CrossRef
22.
Zurück zum Zitat Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–5.CrossRef Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–5.CrossRef
23.
Zurück zum Zitat Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68–74.CrossRef Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68–74.CrossRef
24.
Zurück zum Zitat Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Exome Aggregation C. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.CrossRef Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Exome Aggregation C. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.CrossRef
25.
Zurück zum Zitat Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990;323:1302–7.CrossRef Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990;323:1302–7.CrossRef
26.
Zurück zum Zitat Nakazawa M, Kikawa-Araki E, Shiono T, Tamai M. Analysis of rhodopsin gene in patients with retinitis pigmentosa using allele-specific polymerase chain reaction. Jpn J Ophthalmol. 1991;35:386–93.PubMed Nakazawa M, Kikawa-Araki E, Shiono T, Tamai M. Analysis of rhodopsin gene in patients with retinitis pigmentosa using allele-specific polymerase chain reaction. Jpn J Ophthalmol. 1991;35:386–93.PubMed
27.
Zurück zum Zitat Shiono T, Hotta Y, Noro M, Sakuma T, Tamai M, Hayakawa M, et al. Clinical features of Japanese family with autosomal dominant retinitis pigmentosa caused by point mutation in codon 347 of rhodopsin gene. Jpn J Ophthalmol. 1992;36:69–75.PubMed Shiono T, Hotta Y, Noro M, Sakuma T, Tamai M, Hayakawa M, et al. Clinical features of Japanese family with autosomal dominant retinitis pigmentosa caused by point mutation in codon 347 of rhodopsin gene. Jpn J Ophthalmol. 1992;36:69–75.PubMed
28.
Zurück zum Zitat Hosono K, Ishigami C, Takahashi M, Park DH, Hirami Y, Nakanishi H, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS ONE. 2012;7:e31036.CrossRef Hosono K, Ishigami C, Takahashi M, Park DH, Hirami Y, Nakanishi H, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS ONE. 2012;7:e31036.CrossRef
29.
Zurück zum Zitat Iwanami M, Oshikawa M, Nishida T, Nakadomari S, Kato S. High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa. Investig Ophthalmol Vis Sci. 2012;53:1033–40.CrossRef Iwanami M, Oshikawa M, Nishida T, Nakadomari S, Kato S. High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa. Investig Ophthalmol Vis Sci. 2012;53:1033–40.CrossRef
Metadaten
Titel
Regional differences in genes and variants causing retinitis pigmentosa in Japan
verfasst von
Yoshito Koyanagi
Masato Akiyama
Koji M Nishiguchi
Yukihide Momozawa
Yoichiro Kamatani
Sadaaki Takata
Chihiro Inai
Yusuke Iwasaki
Mikako Kumano
Yusuke Murakami
Shiori Komori
Dan Gao
Kentaro Kurata
Katsuhiro Hosono
Shinji Ueno
Yoshihiro Hotta
Akira Murakami
Hiroko Terasaki
Yuko Wada
Toru Nakazawa
Tatsuro Ishibashi
Yasuhiro Ikeda
Michiaki Kubo
Koh-Hei Sonoda
Publikationsdatum
25.02.2021
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 3/2021
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-021-00824-w

Neu im Fachgebiet Augenheilkunde

Kompetente Gesprächsführung

Mit schwierigen Gesprächen und der Übermittlung schlechter Nachrichten ist der Augenarzt/die Augenärztin im Krankenhaus und in der Praxis immer wieder konfrontiert. Eine gute Arzt-Patienten-Kommunikation basiert auf Respekt und Empathie und …

Sekundäre chorioidale Neovaskularisation – Wirklich so häufig?

Das Auftreten einer sekundären chorioidalen Neovaskularisation ist eine Komplikation im Rahmen einer chronischen Chorioretinopathia centralis serosa. Die Diagnose wird mittels multimodaler Bildgebung gestellt. Die Therapie erfolgt in der Regel mit …

Therapie der Chorioretinopathia centralis serosa im Vergleich – Mikrosekundenpulslaser versus photodynamische Therapie

Zum gegenwärtigen Zeitpunkt steht für die Behandlung der Chorioretinopathia centralis serosa (CCS) keine zugelassene Therapie zur Verfügung. Obwohl die CCS eine hohe Selbstresorptionsrate aufweist, können häufige Rezidive oder eine Chronifizierung …

Diagnostik und Klassifikation der Chorioretinopathia centralis serosa – Was brauche ich wirklich?

Die multimodale Bildgebung spielt bei der Diagnostik und Klassifikation der Chorioretinopathia centralis serosa (CCS) eine bedeutende Rolle. In diesem Beitrag sollen die wichtigsten Bildgebungsmodalitäten bei der CCS wie optische …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.